These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Immunology of malignancy. Kaufman JR J Indiana State Med Assoc; 1975 Aug; 68(8):712-5. PubMed ID: 1095658 [No Abstract] [Full Text] [Related]
25. [Problems of cancer immunotherapy (author's transl)]. Gericke D MMW Munch Med Wochenschr; 1977 Nov; 119(46):1497-1500. PubMed ID: 414081 [TBL] [Abstract][Full Text] [Related]
26. Passive immunotherapy of cancer in animals and man. Rosenberg SA; Terry WD Adv Cancer Res; 1977; 25():323-88. PubMed ID: 326003 [No Abstract] [Full Text] [Related]
27. Transfer factor: a potential agent for cancer therapy. LoBuglio AF; Neidhart JA Med Clin North Am; 1976 May; 60(3):585-90. PubMed ID: 775210 [TBL] [Abstract][Full Text] [Related]
28. Transfer factor. Al-Sarraf M; Baker LH Cancer Treat Rev; 1979 Dec; 6(4):209-15. PubMed ID: 394838 [No Abstract] [Full Text] [Related]
29. Fundamentals of active specific immunotherapy of cancer using BCG-tumor cell vaccines. Hanna MG; Peters LC; Hoover HC Prog Clin Biol Res; 1989; 310():51-65. PubMed ID: 2672023 [No Abstract] [Full Text] [Related]
30. An introduction to tumor immunology and immunotherapy. Mitchell MS Gynecol Oncol; 1976 Mar; 4(1):1-12. PubMed ID: 791768 [No Abstract] [Full Text] [Related]
32. BCG, levamisole and transfer factor in the treatment of cancer. Spitler LE Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631 [No Abstract] [Full Text] [Related]